tertatolol has been researched along with Lymphoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
De Blasi, A; Fratelli, M; Marasco, O | 1 |
1 other study(ies) available for tertatolol and Lymphoma
Article | Year |
---|---|
Certain beta-blockers can decrease beta-adrenergic receptor number: I. Acute reduction in receptor number by tertatolol and bopindolol.
Topics: Adrenergic beta-Antagonists; Binding, Competitive; Humans; Leukocytes, Mononuclear; Lymphoma; Male; Pindolol; Propanolamines; Receptors, Adrenergic, beta; Stereoisomerism; Sympathomimetics; Thiophenes; Tumor Cells, Cultured | 1988 |